Charts

iSpecimen Inc. (NASDAQ:ISPC) Q4 2022 Earnings Call Transcript March 14, 2023 Operator: Good day, everyone and welcome to iSpecimen’s Full Year 2022 Conference Call. At this time, participants will be in a listen-only mode. A question-and-answer session will follow managements’ remarks. This conference call is being recorded. A replay of today’s call will be available […]

Q4 2022 iSpecimen Inc Earnings Call

- Reported Record Quarterly Revenue of $3.2 Million, Up 28% Year-Over-Year -LEXINGTON, Mass., March 14, 2023 (GLOBE NEWSWIRE) -- iSpecimen Inc. (Nasdaq: ISPC) (“iSpecimen” or the “Company”), an online global marketplace that connects scientists in need of biospecimens for medical research with a network of healthcare specimen providers, today reported its financial and operating results for the twelve-month period ended December 31, 2022. “At the beginning of the fourth quarter of 2022, I steppe

iSpecimen (NASDAQ:ISPC) is set to give its latest quarterly earnings report on Tuesday, 2023-03-14. Here's what investors need to know ...

Award Highlights Businesses at the Forefront of Innovation That Are Transforming Industries and Shaping SocietyLEXINGTON, Mass., March 02, 2023 (GLOBE NEWSWIRE) -- iSpecimen Inc. (Nasdaq: ISPC), an online global marketplace that connects scientists in need of biospecimens for medical research with a network of healthcare specimen providers (“iSpecimen”), has been named to Fast Company’s annual list of the World’s Most Innovative Companies as part of the biotech category for 2023. Fast Company is

LEXINGTON, Mass., Feb. 28, 2023 (GLOBE NEWSWIRE) -- iSpecimen Inc. (Nasdaq: ISPC) (“iSpecimen” or the “Company”), an online global marketplace that connects scientists in need of biospecimens for medical research with a network of healthcare specimen providers, today announced that it will report its financial results for the fourth quarter and full year ended December 31, 2022, before the markets open on Tuesday, March 14, 2023. The Company will host a conference call and audio webcast that mor

iSpecimen Strategically Grows its Proprietary Marketplace Platform with Seven New Biospecimen Sample Providers Across the U.S. and EuropeLEXINGTON, Mass., Feb. 08, 2023 (GLOBE NEWSWIRE) -- iSpecimen Inc. (Nasdaq: ISPC) (“iSpecimen” or the “Company”), an online global marketplace that connects scientists in need of biospecimens for medical research with a network of healthcare specimen providers, today announced that over the course of the second half of 2022, the Company added and onboarded seve

NEW YORK, Jan. 24, 2023 (GLOBE NEWSWIRE) -- Maxim Group LLC, a full-service investment banking, securities and wealth management firm, and M-Vest, a digital community built for issuers, investors, and thought leaders, present the Healthcare IT Virtual Conference. The conference will take place on Wednesday, January 25th at 8:15 A.M. ET Maxim Group LLC presents the Healthcare IT Virtual Conference. Participating companies focus on technology addressing rising health care costs, and scarcity of wo

Mr. Langlois Led iSpecimen to 3,000 Percent Revenue Growth During His Tenure as the Company’s Former SVP of Sales and Business DevelopmentLEXINGTON, Mass., Jan. 24, 2023 (GLOBE NEWSWIRE) -- iSpecimen Inc. (Nasdaq: ISPC) (“iSpecimen” or the “Company”), an online global marketplace that connects scientists in need of biospecimens for medical research with a network of healthcare specimen providers, announced today that it appointed Eric Langlois as Chief Revenue Officer, effective immediately. Mr.

LEXINGTON, Mass., Jan. 23, 2023 (GLOBE NEWSWIRE) -- iSpecimen Inc. (Nasdaq: ISPC) (“iSpecimen” or the “Company”), an online global marketplace that connects scientists in need of biospecimens for medical research with a network of healthcare specimen providers, today announced that Tracy Curley, CEO of iSpecimen, will participate in the Sequire Biotechnology Conference to be held virtually on Thursday, February 2, 2023. Ms. Curley will present at 5:00 p.m. ET. To attend, please register here. Fo

LEXINGTON, Mass., Jan. 19, 2023 (GLOBE NEWSWIRE) -- iSpecimen Inc. (Nasdaq: ISPC) (“iSpecimen” or the “Company”), an online global marketplace that connects scientists in need of biospecimens for medical research with a network of healthcare specimen providers, today announced that Tracy Curley, CEO of iSpecimen, will participate in the Healthcare IT Virtual Conference hosted by Maxim Group and M-Vest on Wednesday, January 25, 2023. Ms. Curley will present at 8:30 a.m. ET. To attend, please regi

Previously Appointed Interim CEO in September 2022LEXINGTON, Mass., Jan. 10, 2023 (GLOBE NEWSWIRE) -- iSpecimen Inc. (Nasdaq: ISPC) (“iSpecimen” or the “Company”), an online global marketplace that connects scientists in need of biospecimens for medical research with a network of healthcare specimen providers, announced today that its Board of Directors has appointed Tracy Curley, former Interim CEO, as CEO, effective immediately. “I am grateful to the Board and the entire team at iSpecimen for

Sought-After Strategic Advisor Brings Expertise in Mergers and Acquisitions, Restructuring and Governance to iSpecimenLEXINGTON, Mass., Dec. 05, 2022 (GLOBE NEWSWIRE) -- iSpecimen Inc. (Nasdaq: ISPC) (“iSpecimen” or the “Company”), an online global marketplace that connects scientists in need of biospecimens for medical research with a network of healthcare specimen providers, announced today that the Company has appointed Joseph J. Basile to iSpecimen’s Board of Directors (the “Board”), as well

- Reported Revenue of $2.6 Million, Comprised Of A Record 88% Non-COVID Revenue -LEXINGTON, Mass., Nov. 08, 2022 (GLOBE NEWSWIRE) -- iSpecimen Inc. (Nasdaq: ISPC) (“iSpecimen” or the “Company”), an online global marketplace that connects scientists in need of biospecimens for medical research with a network of healthcare specimen providers, today reported its financial and operating results for the three- and nine-month period ended September 30, 2022. “During the third quarter of 2022, iSpecime

Usually, when one insider buys stock, it might not be a monumental event. But when multiple insiders are buying like...

New Feature Provides Suppliers with Research Transparency to Optimize Fulfillment ProcessLEXINGTON, Mass., Oct. 27, 2022 (GLOBE NEWSWIRE) -- iSpecimen Inc. (Nasdaq: ISPC) (“iSpecimen” or the “Company”), an online global marketplace that connects scientists in need of biospecimens for medical research with a network of healthcare specimen providers, today announced that the Company has launched its new self-service Open Feasibilities Dashboard on iSpecimen Marketplace®, allowing supplier partners

LEXINGTON, Mass., Oct. 25, 2022 (GLOBE NEWSWIRE) -- iSpecimen Inc. (Nasdaq: ISPC) (“iSpecimen” or the “Company”), an online global marketplace that connects scientists in need of biospecimens for medical research with a network of healthcare specimen providers, today announced that it will report its financial results for the third quarter ended September 30, 2022, before the markets open on Tuesday, November 8, 2022. The Company will host a conference call and audio webcast that morning at 8:30

Gainers Applied Genetic Techs (NASDAQ:AGTC) shares moved upwards by 62.0% to $0.39 during Monday's pre-market session. The ...

Lexington, Massachusetts--(Newsfile Corp. - October 18, 2022) - iSpecimen Inc. (NASDAQ: ISPC) ("iSpecimen" or the "Company"), an online global marketplace that connects scientists in need of biospecimens for medical research with a network of healthcare specimen providers, today announced that Tracy Curley, Interim CEO and CFO of iSpecimen, will present at the ThinkEquity Conference to be held at the Mandarin Oriental Hotel in New York City on October 26, 2022 at 4:30 p.m. ET. ...

What Defines a Value Stock? A value stock is traditionally defined in terms of how investors in the marketplace are valuing that ...

New Program Designed to Support Provider Partners with Onsite CoordinatorLEXINGTON, Mass., Oct. 04, 2022 (GLOBE NEWSWIRE) -- iSpecimen Inc. (Nasdaq: ISPC) (“iSpecimen” or the “Company”), an online global marketplace that connects scientists in need of biospecimens for medical research with a network of healthcare specimen providers, today launched its new Marketplace Onsite program to offer additional support to the Company’s biospecimen provider partners. The program embeds a coordinator at sel

Gainers LAVA Therapeutics N.V. (NASDAQ: LVTX) shares jumped 97% to $4.71 after the company and Seagen Inc (NASDAQ: SGEN) ...

Gainers RedHill Biopharma Ltd. (NASDAQ: RDHL) rose 31.4% to $0.6525 in pre-market trading after dipping over 20% on Friday. The ...

Gainers Spero Therapeutics, Inc. (NASDAQ: SPRO) shares jumped 167.7% to close at $2.20 on Thursday after the company announced it ...

Current President and CEO, Christopher Ianelli, to Leave CompanyLEXINGTON, Mass., Sept. 22, 2022 (GLOBE NEWSWIRE) -- iSpecimen Inc. (Nasdaq: ISPC) (“iSpecimen” or the “Company”), an online global marketplace that connects scientists in need of biospecimens for medical research with a network of healthcare specimen providers, announced today the immediate appointment of Tracy Curley as interim CEO, replacing current Chief Executive Officer and President, Christopher Ianelli. In addition to servin

Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. For the Vanguard Total Stock Market ETF (VTI), we found that the implied analyst target price for the ETF based upon its underlying holdings is $241.91 per unit.

Gainers BioVie (NASDAQ:BIVI) stock increased by 32.3% to $4.55 during Wednesday's pre-market session. The ...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Good morning! It's time for another look at the biggest pre-market stock movers as we see why shares are moving Wednesday morning! The post Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday appeared first on InvestorPlace. More From InvestorPlace Buy This $5 Stock BEFORE This Apple Project Goes Live The Best $1 Investment You Can Make Today Early Bitcoin Millionaire Reveals His Next Big Crypto Trade “On Air” It doesn’t matter if you have $500 or $5 million. Do this now.

LEXINGTON, Mass., Aug. 31, 2022 (GLOBE NEWSWIRE) -- iSpecimen Inc. (Nasdaq: ISPC) ("iSpecimen" or the "Company"), an online global marketplace that connects scientists in need of biospecimens for medical research with a network of healthcare specimen providers, today announced that Christopher Ianelli, MD, PhD, CEO and President of iSpecimen, will participate in the H.C. Wainwright 24th Annual Global Investment Conference to be held at the Lotte New York Palace Hotel in New York City on Septembe

Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. For the Vanguard Total Stock Market ETF (VTI), we found that the implied analyst target price for the ETF based upon its underlying holdings is $244.41 per unit.

Gainers Aditxt (NASDAQ:ADTX) stock increased by 80.8% to $0.29 during Friday's regular session. Aditxt's stock ...

Gainers United Maritime Corporation (NASDAQ: USEA) climbed 147.6% to close at $7.08 on Thursday on heavy momentum following the ...

Gainers United Maritime Corporation (NASDAQ: USEA) jumped 180.4% to $8.02. The company’s stock jumped 190% on Wednesday ...

iSpecimen Inc(NASDAQ: ISPC) hasadded new global biospecimen suppliersto its proprietary Marketplace platform for ...

Gainers NeuroBo Pharmaceuticals (NASDAQ:NRBO) stock rose 14.5% to $0.53 during Tuesday's after-market session. The company's market ...

Gainers Redhill Biopharma (NASDAQ:RDHL) stock moved upwards by 16.4% to $0.89 during Friday's pre-market session. The market value of ...

Gainers Genocea Biosciences (NASDAQ:GNCA) stock rose 36.0% to $0.08 during Wednesday's regular session. Trading ...

Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. For the iShares Micro-Cap ETF (IWC), we found that the implied analyst target price for the ETF based upon its underlying holdings is $179.75 per unit.

Gainers Allena Pharma (NASDAQ:ALNA) stock increased by 94.9% to $0.15 during Thursday's pre-market session. The ...

Gainers Vivakor, Inc. (NASDAQ: VIVK) shares jumped 113.5% to close at $3.65 on Wednesday after the company announced it has signed ...

Gainers Longeveron Inc. (NASDAQ: LGVN) shares jumped 105.4% to close at $13.80 on Thursday after the company announced the ...

Gainers Immutep (NASDAQ:IMMP) stock rose 18.1% to $3.39 during Wednesday's after-market session. Today's trading volume for this ...

Gainers Creative Medical Tech (NASDAQ:CELZ) stock increased by 14.6% to $1.8 during Thursday's after-market session. At the close, ...

On Thursday, 147 companies achieved new lows for the year. Significant Points From Today's 52-Week ...

Companies Reporting Before The Bell • Palantir Technologies (NYSE:PLTR) is estimated to report quarterly earnings at ...

Gainers Splash Beverage Group, Inc. (NASDAQ: SBEV) shares gained 118.9% to settle at $4.18 on Friday. Splash Beverage recently ...

Gainers ATI Physical Therapy, Inc. (NYSE: ATIP) shares gained 25.2% to $3.8050 after Jefferies upgraded the stock from Hold to ...

ISpecimen Inc (NASDAQ: ISPC) is trading higher Thursday after the companyannounced the addition of a reference lab in New York to ...

Gainers ATA Creativity Global (NASDAQ: AACG) gained 114.3% to close at $2.55. Hoth Therapeutics, Inc. (NASDAQ: HOTH) surged ...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips ISPC stock received a $20 price target from Craig-Hallum today. This comes after iSpecimen made several developments during 2021. The post ISPC Stock: What Is Going on With Little-Known iSpecimen Today? appeared first on InvestorPlace. More From InvestorPlace Stock Prodigy Who Found NIO at $2… Says Buy THIS Now Man Who Called Black Monday: “Prepare Now.” #1 EV Stock Still Flying Under the Radar Interested in Crypto? Read This First...

Craig-Halluminitiated coverage ofiSpecimen Inc(NASDAQ: ISPC) with a Buy rating and $20 price ...

Gainers TherapeuticsMD, Inc. (NASDAQ: TXMD) jumped 31.7% to $0.5185 after it announced that the FDA approved a low dose version of ...

Upgrades According to Vertical Research, the prior rating for Livent Corp (NYSE:LTHM) was changed from Hold to Buy. ...

Following the market opening Tuesday, the Dow traded up 0.74% to 36,857.55 while the NASDAQ fell 0.14% to 15,811.30. The S&P also ...

Gainers Microbot Medical Inc. (NASDAQ: MBOT) shares climbed 65.1% to close at $8.95 on Monday after the company announced a ...

Gainers Microbot Medical Inc. (NASDAQ: MBOT) shares jumped 69.6% to $9.19 after the company announced a strategic collaboration ...

Gainers Society Pass Incorporated (NASDAQ: SOPA) shares surged 53.4% to settle at $16.31 on Wednesday. Acasti Pharma Inc. ...

Gainers Red Cat Holdings, Inc. (NASDAQ: RCAT) shares surged 31.7% to $2.41 after the company announced it was awarded a multiple ...

Gainers BioRestorative Therapies, Inc.(NASDAQ: BRTX) rose 48.1% to $6.77 in pre-market trading after the company entered ...

Gainers Reliance Global Group, Inc. (NASDAQ: RELI) shares jumped 78.7% to close at $5.45 on Tuesday after gaining around 6% on ...

Since the market has dropped so much, now might be the time to look for short squeeze opportunities.